Evidence map›Paper›PMID 39538008›Full record

ArticleScientific reports2024

Impact of mixed Staphylococcus aureus-Pseudomonas aeruginosa biofilm on susceptibility to antimicrobial treatments in a 3D in vitro model.

Guillermo Landa, Jonathan Clarhaut, Julien Buyck, Gracia Mendoza, Manuel Arruebo, Frederic Tewes

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. MRSA-dominant colonization and synergistic pathogenicity withJournal of orthopaedic translation · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Optimization ofInternational journal of molecular sciences · 2026
    Article
  9. Eradication ofInternational journal of microbiology · 2026
    Article
  10. Article
  11. Frontiers in cellular and infection microbiology · 2026
    Article
  12. Journal of bacteriology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Guillermo LandaAragon Institute of Nanoscience and Materials (INMA), CSIC-University of Zaragoza, Zaragoza, 50009, Spain. glanda@unizar.es.
Jonathan ClarhautINSERM U1070 "Pharmacology of antimicrobial agents and resistances", University of Poitiers, Pôle Biologie Santé, 1 rue Georges Bonnet, Poitiers, 86022, France.
Julien BuyckINSERM U1070 "Pharmacology of antimicrobial agents and resistances", University of Poitiers, Pôle Biologie Santé, 1 rue Georges Bonnet, Poitiers, 86022, France.
Gracia MendozaAragon Health Research Institute (IIS Aragon), Zaragoza, 50009, Spain. gmendoza@iisaragon.es.
Manuel ArrueboAragon Institute of Nanoscience and Materials (INMA), CSIC-University of Zaragoza, Zaragoza, 50009, Spain.
Frederic TewesINSERM U1070 "Pharmacology of antimicrobial agents and resistances", University of Poitiers, Pôle Biologie Santé, 1 rue Georges Bonnet, Poitiers, 86022, France.

Funding

Ministerio de Ciencia e Innovación PID2020-113987RB-I00 and PDC2021-121405-I00
6 · The paper itself

Abstract

Staphylococcus aureus and Pseudomonas aeruginosa are the most common bacteria co-isolated from chronic infected wounds. Their interactions remain unclear but this coexistence is beneficial for both bacteria and may lead to resistance to antimicrobial treatments. Besides, developing an in vitro model where this coexistence is recreated remains challenging, making difficult their study. The aim of this work was to develop a reliable polymicrobial in vitro model of both species to further understand their interrelationships and the effects of different antimicrobials in coculture. In this work, bioluminescent and fluorescent bacteria were used to evaluate the activity of two antiseptics (chlorhexidine and thymol) against these bacteria planktonically grown, or when forming single and mixed biofilms. At the doses tested (0.4-1,000 mg/L), thymol showed selective antimicrobial action against S. aureus in planktonic and biofilm states, in contrast with chlorhexidine which exerted antimicrobial effects against both bacteria. Furthermore, the initial conditions for both bacteria in the co-culture determined the antimicrobial outcome, showing that P. aeruginosa impaired the proliferation and metabolism of S. aureus. Moreover, S. aureus showed an increased tolerance against antiseptic treatments when co-cultured, attributed to the formation of a thicker mixed biofilm compared to those obtained when monocultured, and also, by the reduction of S. aureus metabolic activity induced by diffusible molecules produced by P. aeruginosa. This work underlines the relevance of polymicrobial populations and their crosstalk and microenvironment in the search of disruptive and effective treatments for polymicrobial biofilms.

Indexed as

BiofilmsChlorhexidineCoculture TechniquesMicrobial Sensitivity TestsPseudomonas aeruginosaStaphylococcus aureusAnti-Bacterial AgentsAnti-Infective Agents, LocalHumansThymolAnti-Bacterial AgentsAnti-Infective Agents, LocalChlorhexidineThymolAntisepticsChlorhexidinePolymicrobial biofilmPseudomonas aeruginosaStaphylococcus aureusThymol

Identifiers

PMID39538008
PMCPMC11561256

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.